Cargando...
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurological disorder predominantly characterized by motor symptoms including bradykinesia and resting tremor. The gold standard of treatment for PD remains dopamine replacement therapy, which eventually fails due to continued progression of the disease and...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3603000/ https://ncbi.nlm.nih.gov/pubmed/23526920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.12.6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|